Unspecified Adult Solid Tumor

Explore clinical trials studying Unspecified Adult Solid Tumor. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Unspecified Adult Solid Tumor trial results

Active, not recruiting

Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases

NCT01843413

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +7 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT02049593

Conditions: Metastatic Cancer, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

NCT00390156

Conditions: Unspecified Adult Solid Tumor
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

NCT02324621

Conditions: Unspecified Adult Solid Tumor
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors

NCT01450384

Conditions: Unspecified Adult Solid Tumor
Locations: Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

NCT00477607

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, +7 more
Locations: VA Medical Center, Portland Portland, Oregon, United States

Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

NCT00037804

Conditions: Chemotherapy, Digestive System Diseases, Liver Diseases, +4 more
Locations: Research Center Detroit, Michigan, United States

Research Center New Brunswick, New Jersey, United States

Research Center Nashville, Tennessee, United States

Research Center Marshfield, Wisconsin, United States

View Trial Details

Unspecified Adult Solid Tumor

Unspecified Adult Solid Tumor trial results

Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases

PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors

Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

Related conditions